Sterile Drug GMPs: CCS Tool Could Help Bridge Compliance Gaps As Annex 1 Revisions Take Effect

 
• By Bowman Cox

Experts who led PDA’s interactions with EU, PIC/S and WHO authorities on first-ever comprehensive revision of sterile drug product manufacturing guidance recently shared insights on implementation priorities with the Pink Sheet.

Closing the gap
a new strategy for closing compliance gaps • Source: Shutterstock

More from Manufacturing

More from Compliance